Edges in Network
| Network | GSE14208_egf1520 - GSE14208 - SiGN-BN HC+Bootstrap |
| Network Description | Clinical response of metastatic gastric cancer patients to cisplatin and fluorouracil (CF) combination chemotherapy |
| Node | CEP170 |
| Upstream (Parents) |
|---|
| (<<) CHST3 → CEP170 |
| (<<) CXCR7 → CEP170 |
| (<<) CYR61 → CEP170 |
| (<<) ELK3 → CEP170 |
| (<<) INHBA → CEP170 |
| (<<) INVS → CEP170 |
| (<<) MAPK3 → CEP170 |
| (<<) MSN → CEP170 |
| (<<) NFATC1 → CEP170 |
| (<<) VEGFC → CEP170 |
| Downstream (Children) |
|---|
| CEP170 → ADAM12 (>>) |
| CEP170 → ADAM19 (>>) |
| CEP170 → ADCY7 (>>) |
| CEP170 → AKT3 (>>) |
| CEP170 → B3GNT3 (>>) |
| CEP170 → BCL2A1 (>>) |
| CEP170 → CHSY1 (>>) |
| CEP170 → CREBBP (>>) |
| CEP170 → CRLF3 (>>) |
| CEP170 → CSGALNACT2 (>>) |
| CEP170 → CYP1B1 (>>) |
| CEP170 → CYP27B1 (>>) |
| CEP170 → DDX18 (>>) |
| CEP170 → DNM2 (>>) |
| CEP170 → DOCK9 (>>) |
| CEP170 → DVL3 (>>) |
| CEP170 → ELF3 (>>) |
| CEP170 → ELOVL1 (>>) |
| CEP170 → EPN3 (>>) |
| CEP170 → FZD5 (>>) |
| CEP170 → GLS (>>) |
| CEP170 → GNG10 (>>) |
| CEP170 → HS2ST1 (>>) |
| CEP170 → IDI1 (>>) |
| CEP170 → ITGB1 (>>) |
| CEP170 → KCNJ2 (>>) |
| CEP170 → KLF11 (>>) |
| CEP170 → LARP6 (>>) |
| CEP170 → MAP3K8 (>>) |
| CEP170 → MAPK9 (>>) |
| CEP170 → MTHFD2 (>>) |
| CEP170 → NOTCH2 (>>) |
| CEP170 → PFKFB3 (>>) |
| CEP170 → PHLDA1 (>>) |
| CEP170 → PLCB3 (>>) |
| CEP170 → PLOD2 (>>) |
| CEP170 → PPP1CA (>>) |
| CEP170 → PRKCD (>>) |
| CEP170 → PRKCDBP (>>) |
| CEP170 → RCBTB1 (>>) |
| CEP170 → RHOF (>>) |
| CEP170 → RPS6KA1 (>>) |
| CEP170 → RRAS2 (>>) |
| CEP170 → SMURF2 (>>) |
| CEP170 → SOCS5 (>>) |
| CEP170 → SP3 (>>) |
| CEP170 → SULF1 (>>) |
| CEP170 → THBS1 (>>) |
| CEP170 → VPS28 (>>) |
| CEP170 → WNT4 (>>) |
| CEP170 → WNT5A (>>) |
| CEP170 → ZNF365 (>>) |
